Howard Beaty — Asked where the formulary recommendations come from and what process is used to bring them before the committee.
Andrew Collins — Representative Collins asks whether the premium increases are the only change in the renewal and whether anything else is becoming more burdensome.
Jimmy Hickey — Senator Hickey is called on with a question about the RFQ process and vendor responses.
Jimmy Hickey — Senator Jimmy Hickey is called on next, but his question is deferred until after Mr. Wallace speaks.
Jimmy Hickey — Invited to proceed with his question.
Patrick Klein — Introduces himself as being with the Segal Group and presents analysis of the public school plans funding reserve.
Jonathan Dismang — Senator Jonathan Dismang was called on first to ask questions, and later he was thanked for his earlier question, indicating a single continuous exchange centered on his participation.
Jonathan Dismang — Senator Dismang is called from the question queue and then asks how much additional money EBD receives under the direct-pay model compared with routing payments through school districts.
Jonathan Dismang — Jonathan Dismang is referenced in the context of a discussion about wellness visits, with the speaker acknowledging him and noting shared concerns or experiences related to that topic before moving on.
Alan Clark — Likely the member being addressed as 'Representative Garner' is not in the expected list; the transcript says 'Representative Garner' and is left as-is as questionable.
Dave Wallace — Mr. Wallace was asked to come to the table for the next exchange.
Siegel — Senator Irwin asks Siegel to explain the difference between prior actions and the current situation.
Siegel — Described as the committee's consultant, working with the speaker on actionable recommendations.
Clarke Tucker — Senator Tucker asks about how recommendations will be made and how funding decisions will be brought back to the committee. In the follow-up discussion, other speakers refer back to Tucker’s point, noting that he had raised the issue of bringing a plan forward and framing their comments around that same process.
Jim Petty — Jim Petty asked to revisit the targeted reserve balance, noting that the reserve target should be reconsidered in light of current projections and conditions. He argued that the lower end of the range may be too aggressive and said he would favor a six-month reserve level rather than a three-month level because it takes time to respond to a crisis.
Patrick — Patrick is brought into the discussion to clarify the analysis and current conditions. He explains the date comparison behind the 45% figure, noting it compares a 2026 current projection from PCG with Millman’s projection from two years earlier. The conversation then shifts to pharmacy spend calculations, where Patrick is asked whether rebates are included and whether RX claims are offset by rebates. He responds that only claims are being counted and that revenue-side offsets may exist, meaning the analysis may not capture all offsets.